| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8691280 | World Neurosurgery | 2018 | 8 Pages |
Abstract
Gross total removal of the PIMM was the most promising treatment. Currently adjuvant therapy has not been associated with the survival period. To improve clinical outcome, immunotherapy and targeted therapies are likely to become more important.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Nobuhiko Arai, Hiroshi Kagami, Yutaka Mine, Toshiharu Ishii, Makoto Inaba,